Description
DEOBLIGATE FUNDS ON AN ESTIMATED TASK ORDER TO APHENA FOR THE PHARM REPACKAGING PROGRAM - 3RD QUARTER FY2018
Base award description: ESTIMATED DISTRIBUTION AND REPACKAGING FEES FOR APHENA FOR THE PHARM REPACKAGING PROGRAM - 3RD QUARTER FY2018
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2018-04-04+$1,589,153= $1,589,153
- Mod P000012018-07-05+$0= $1,589,153
- Mod P000022018-07-09+$0= $1,589,153
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2018-04-04 | +$1,589,153 | $1,589,153 | ESTIMATED DISTRIBUTION AND REPACKAGING FEES FOR APHENA FOR THE PHARM REPACKAGING PROGRAM - 3RD QUARTER FY2018 |
| Mod P00001· FUNDING ONLY ACTION | 2018-07-05 | +$0 | $1,589,153 | DEOBLIGATE FUNDS ON AN ESTIMATED TASK ORDER TO APHENA FOR THE PHARM REPACKAGING PROGRAM - 3RD QUARTER FY2018 |
| Mod P00002· FUNDING ONLY ACTION | 2018-07-09 | +$0 | $1,589,153 | DEOBLIGATE FUNDS ON AN ESTIMATED TASK ORDER TO APHENA FOR THE PHARM REPACKAGING PROGRAM - 3RD QUARTER FY2018 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KE13UAQL1N24)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026N0032 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $7,200,000 | FY2026 |
| 36C77026D0009 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36E79725N0033 | NAC PHARMACEUTICALS (36E797) · Q999 · MEDICAL- OTHER | $270,899 | FY2025 |
| 36C77025K0073 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $219,077 | FY2025 |
| 36C77025K0061 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $307,076 | FY2025 |
| 36C77025K0074 | NATIONAL CMOP OFFICE (36C770) · Q999 · MEDICAL- OTHER | $425,910 | FY2025 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36E79718N0044_3600_VA797P17C0025_3600 · retrieved 2026-09-26.